From poison to lifeline – how my views on chemotherapy changed as a cancer patientCancer survivor Brooke Gant tells us about her experiences with chemotherapy. In 2017, I started off being a Share XFrom poison to lifeline – how my views on chemotherapy changed as a cancer patienthttps://pharmaphorum.com/views-analysis-patients/from-poison-to-lifeline-how-my-views-on-chemotherapy-changed-as-a-cancer-patient/
Boosting clinical trial recruitment through patient engagementOver the years, many hands have been wrung over clinical trial recruitment – low participation rates are common Share XBoosting clinical trial recruitment through patient engagementhttps://pharmaphorum.com/views-analysis-patients/boosting-clinical-trial-recruitment-through-patient-engagement/
The unmet needs of bleeding disorder patientsAhead of eyeforpharma Philadelphia 2019, we talk to speaker and haemophilia advocate Michelle Rice about the changing landscape Share XThe unmet needs of bleeding disorder patientshttps://pharmaphorum.com/views-analysis-patients/the-unmet-needs-of-bleeding-disorder-patients/
Success comes from listening to and working with patientsWith the current mainstay of Parkinson’s treatment being more than 50 years old and doing nothing to slow Share XSuccess comes from listening to and working with patientshttps://pharmaphorum.com/views-analysis-patients/success-comes-from-listening-to-and-working-with-patients/
Pharma must put patients at the centre of the shift to value-based careThe pharma industry has been talking about the healthcare sector’s move to value-based care for some time. Even Share XPharma must put patients at the centre of the shift to value-based carehttps://pharmaphorum.com/views-analysis-patients/pharma-must-put-patients-at-the-centre-of-the-shift-to-value-based-care/
Listening to the myeloma patient voice is difficult – but it still needs to be doneOver the last decade, treatments for the blood cancer myeloma have come on in leaps and bounds – Share XListening to the myeloma patient voice is difficult – but it still needs to be donehttps://pharmaphorum.com/views-analysis-patients/listening-myeloma-patient-voice-difficult-but-needs-to-be-done/
Eyeforpharma Barcelona 2019 roundupThis year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting Share XEyeforpharma Barcelona 2019 rounduphttps://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/
How T-cell therapy saved my lifeJudy Perkins’ stage 4 cancer was eradicated after she joined a clinical trial for T-cell therapy. She shares Share XHow T-cell therapy saved my lifehttps://pharmaphorum.com/views-analysis-patients/how-t-cell-therapy-saved-my-life/
How can pharma companies win the trust of Generation Z?The information age has produced a generation of young people concerned about their health, but distrustful of big Share XHow can pharma companies win the trust of Generation Z?https://pharmaphorum.com/views-and-analysis/how-can-pharma-companies-win-the-trust-generation-z/
